Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

International draft guidance on a single-audit program for device facilities is expected out by the end of the month, ECRI weighs in on UDI proposed rule, and more regulatory updates.

You may also be interested in...



CoAxia’s NeuroFlo Catheter For Stroke Shot Down By Panel

FDA’s Neurological Devices panel found that the benefits of the catheter system do not outweigh the risks for the intended expanded use to treat acute ischemic stroke, and that further studies are needed.

Regulatory News In Brief

FDA amends UDI proposed rule. Comments sought on pre-market approval exemption for custom devices. More regulatory news.

As GHTF Ends, Industry Cautiously Optimistic On Future Harmonization Progress Under IMDRF

As the Global Harmonization Task Force held its final meeting last week in Tokyo, members of industry met separately to discuss how GHTF’s work will be carried on by the International Medical Device Regulators Forum.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031675

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel